PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1489957
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1489957
US Angioplasty Balloons Market is valued approximately at USD 619.28 million in 2023 and is anticipated to grow with a healthy growth rate of more than 2.60% over the forecast period 2024-2032. Angioplasty balloons are medical devices in order to treat blocked or constricted blood arteries, especially in the heart and other parts of the body. The damaged artery is opened by inserting a catheter with a connected balloon, which is then inflated at the blockage location to compress the plaque or fatty deposits and enlarge the conduit and restore blood flow. This procedure enhances cardiovascular health in general by reducing symptoms of diseases including peripheral arterial disease and coronary artery disease. Drug-coated angioplasty balloons and bioresorbable stents are becoming increasingly popular because they provide better long-term results and increased effectiveness over conventional devices. Furthermore, a growing number of angioplasty techniques are using artificial intelligence (AI) and machine learning, which allows for more accurate treatment planning and improved patient results. These trends highlight the US angioplasty balloons market's ongoing need for improved treatment alternatives and patient care. Accordingly, the increasing demand for innovative technologies and techniques to address complex cardiovascular conditions is a key trend for the US Angioplasty Balloons Market.
The rising prevalence of various cardiovascular conditions such as atherosclerosis and peripheral arterial disease and region's strong healthcare infrastructure are the key factors that are bolstering the demand of the US Angioplasty Balloons Market at a substantial rate. According to the Journal of the American College of Cardiology published in February 2023, the incidence rate of atherosclerotic cardiovascular disease per 1,000 person-years was 2.60 among those with raised 10-year predicted risk, 1.87 among those with low 10-year however increased 30-year predicted risk, and 0.32 among those with low 10-year and 30-year predicted risk. Furthermore, favorable regulatory policies and approvals for innovative angioplasty devices have encouraged market players to invest in research and development, leading to new product launches and market expansion, which are further presenting various growth prospects to the US Angioplasty Balloons Market during the forecast period. However, high costs associated with the procedure, coupled with the complications associated with angioplasty procedures is expected to stifle US Angioplasty Balloons Market growth between 2022 and 2032.